Kenzo Sonoda

Author PubWeight™ 10.44^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.	Clin Cancer Res	2005	1.99
2	Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.	Cancer Res	2004	1.41
3	Validation of HB-EGF and amphiregulin as targets for human cancer therapy.	Biochem Biophys Res Commun	2007	1.27
4	Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy.	Int J Clin Oncol	2010	1.00
5	Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer.	Cancer Lett	2003	0.96
6	Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer.	Int J Cancer	2009	0.87
7	HOP/NECC1, a novel regulator of mouse trophoblast differentiation.	J Biol Chem	2007	0.83
8	Low-dose mithramycin exerts its anticancer effect via the p53 signaling pathway and synergizes with nutlin-3 in gynecologic cancers.	Cancer Sci	2010	0.81
9	An improved method for isolation of epithelial and stromal cells from the human endometrium.	J Reprod Dev	2016	0.75
10	Apoptotic function of tumor-associated antigen RCAS1 in oral squamous cell carcinoma.	J Transl Med	2014	0.75
11	Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.	Am J Surg Pathol	2017	0.75
12	Expression of RCAS1 in female genital organs.	Int J Gynecol Pathol	2005	0.75
13	Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.	Int J Clin Oncol	2004	0.75